XELLERA THERAPUTICS
Live / Registered — Registered (as of 01 Dec 2020)
What this means for you
Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88977235
- Registration number
- 6211225
- Mark type
- Word mark
- Filed
- 27 May 2019
- Published for opposition
- 28 Apr 2020
- Registered
- 01 Dec 2020
- Attorney of record
- Kevin O'Keefe
Goods and services
- Class 009 — Scientific and electric apparatus: bioreactor for cell culturing; Bioreactors for laboratory use; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Computer-controlled electronic apparatus for electrophysiological measurement and testing of cells
- Class 010 — Medical apparatus: Apparatus for the regeneration of stem cells for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical diagnostic apparatus for testing blood antigens and antibodies
- Class 040 — Treatment of materials: Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; Contract manufacturing in the field of biotechnology; Cryogenic preservation; Cryopreservation of human tissue; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacture of pharmaceuticals to order and/or specification of others; Manufacturing services for others in the field of stem cells; Providing technical information in the field of pharmaceutical manufacturing
- Class 042 — Scientific and technological services: Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug discovery services; Industrial research in the field of regenerative and reparative therapies; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of gene therapy; Stem cell research services; Technology research in the field of regenerative and reparative therapies
- Class 044 — Medical, beauty and agricultural services: Blood bank services; Health care services, namely, regenerative and reparative therapies; Human tissue bank services; Medical care; Medical services; Medical services in the field of regenerative and reparative therapies; Medical testing for diagnostic or treatment purposes in the field of regenerative and reparative therapies; Organ and tissue bank services; Stem cell therapy services
Owner
- XELLERA THERAPEUTICS LIMITED, HUNG HOM, KLN, HK
- XELLERA THERAPEUTICS LIMITED, HUNG HOM, KLN, HK
- XELLERA THERAPEUTICS LIMITED, HUNG HOM, KLN, HK
Prosecution history
- 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2020 — REVIEW OF CORRESPONDENCE COMPLETE
- 29 Oct 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 07 Oct 2020 — NOTICE OF ALLOWANCE CANCELLED
- 07 Oct 2020 — TEAS DELETE 1(B) BASIS RECEIVED
- 23 Jun 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2020 — PUBLISHED FOR OPPOSITION
- 08 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Mar 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2020 — DIVISIONAL PROCESSING COMPLETE